Literature DB >> 1921161

Inhibition of immunoglobulin production by parathyroid hormone. Implications in chronic renal failure.

Z Gaciong1, J M Alexiewicz, M Linker-Israeli, I A Shulman, T O Pitts, S G Massry.   

Abstract

Available data indicate that B cell proliferation is inhibited in chronic renal failure and this is due to excess blood levels of PTH. This defect may also affect immunoglobulin production. We examined production of IgG, IgM and IgA by B cells stimulated with Staphylococcus aureus Cowan I (SAC) or with pokeweed mitogen (PWM) after eight days of culture and evaluated the effect of PTH on this process in 34 hemodialysis patients and 44 normal subjects. IgG, IgM and IgA production by B cells from patients was lower (P less than 0.01) than by B cells from normal subjects. Both 1-34 and 1-84 PTH inhibited (P less than 0.01) immunoglobulin production by B cells from normal subjects and dialysis patients. However, this inhibitory effect was evident in dialysis patients only with the higher dose of PTH. The inhibition of immunoglobulin production by PTH occurred only when the hormone was added at the initiation of the B cell culture. Inactivation of PTH abolished its inhibitory effect on immunoglobulin production. Agents that stimulate cAMP production (forskolin, cholera toxin) and the cAMP analogue, 8-bromoadenosine 3',5' cyclic monophosphate inhibited immunoglobulin production by B cells from both normal and dialysis patients, and the degree of inhibition was not different between the two groups. The calcium inophore A23187 also inhibited IgG, IgA and IgM production by B cells from normal subjects and dialysis patients; there was no significant difference in the degree of inhibition between the two groups. The resting levels of cytosolic calcium in B cells of dialysis patients was significantly (P less than 0.01) higher than that of B cells from normal subjects. The data show that: (1) immunoglobulin production is impaired in dialysis patients; (2) B cells of dialysis patients have elevated resting levels of cytosolic calcium; (3) PTH inhibits IgG, IgA and IgM production and this effect is at least partly mediated by PTH-induced cAMP production and alterations in cytosolic calcium into B cells; (4) this inhibitory effect is mediated by events that affect initial stages of B cell proliferation and maturation; (5) the requirement for high dose of PTH for its inhibitory effect on B cells from dialysis patients is probably due to desensitization and/or down-regulation of PTH receptors on B cells. The results are consistent with the proposition that impaired immunoglobulin production by B cells from dialysis patients is at least partly due to the state of secondary hyperparathyroidism in these patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1921161     DOI: 10.1038/ki.1991.186

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  7 in total

1.  PTH Signaling in Osteoprogenitors Is Essential for B-Lymphocyte Differentiation and Mobilization.

Authors:  Cristina Panaroni; Keertik Fulzele; Vaibhav Saini; Rhiannon Chubb; Paola Divieti Pajevic; Joy Y Wu
Journal:  J Bone Miner Res       Date:  2015-07-20       Impact factor: 6.741

2.  Beyond Bone: Infectious Diseases and Immunity in Parathyroid Disorders.

Authors:  Valeria Hasenmajer; Giulia Puliani; Marianna Minnetti; Emilia Sbardella; Claudio M Mastroianni; Gabriella D'Ettorre; Andrea M Isidori; Daniele Gianfrilli
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

3.  Predictors of hyperkalemia after total parathyroidectomy in patients with drug-refractory secondary hyperparathyroidism.

Authors:  Xi Zhu; Zhouting Li; Xiaofang Xia; Xiaomin Zeng; Feng Cheng; Bin Zhou; Yong Wu; Lei Zhu
Journal:  Gland Surg       Date:  2022-04

4.  Interleukin-6 production and secretion by human parathyroids.

Authors:  S A Safley; F Villinger; E H Jackson; C Tucker-Burden; C Cohen; C J Weber
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

Review 5.  Effects of parathyroid hormone on immune function.

Authors:  Abdallah Sassine Geara; Mario R Castellanos; Claude Bassil; Georgia Schuller-Levis; Eunkue Park; Marianne Smith; Michael Goldman; Suzanne Elsayegh
Journal:  Clin Dev Immunol       Date:  2010-09-16

6.  A new paradigm for the treatment of secondary hyperparathyroidism.

Authors:  Angel L M de Francisco; Fernando Carrera
Journal:  NDT Plus       Date:  2008-01

7.  Potential role of the soluble form of CD40 in deficient immunological function of dialysis patients: new findings of its amelioration using polymethylmethacrylate (PMMA) membrane.

Authors:  Cécile Contin-Bordes; Adeline Lacraz; Valérie de Précigout
Journal:  NDT Plus       Date:  2010-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.